ZBH’s Q1 2025 report. That’s the sign of improved operating efficiencies. The ZBH engine is running well. Good start for the ...

CONMED tried to wrestle supply chain issues into submission for Q1. Made progress, but, as CEO Beyer said, “We have more work ...

Is orthopedics ready for implantable brain chips and telepathic large joint movement? FDA cleared Neuralink’s first implant ...

Centinel Spine and its new “Match the Disc” program, fueled a whopping 33% sales growth rate for Q1, 2025. To put that in ...

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) study for a novel bone graft substitute. What makes this novel, is that this bone graft substitute ...

FDA clears a novel approach to treating osteopenia and osteoporosis. This is the latest venture led by serial Silicon Valley ...

NuVasive loses patent fight over certain pedicle screws and bone anchors. The winning plaintiff is Roger P. Jackson M.D.

Two investigational drugs are progressing through the regulatory pipeline with notable promise, aiming to address two of the most persistent and impactful comorbidities in orthopedic medicine: smoking ...